Suppr超能文献

无定形喷雾干燥分散体的相分离倾向表征

Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.

作者信息

McNamara Daniel, Yin Shawn, Pan Duohai, Crull George, Timmins Peter, Vig Balvinder

机构信息

Drug Product Science and Technology, Bristol-Myers Squibb , One Squibb Drive, New Brunswick, New Jersey 08903, United States.

Drug Product Science and Technology, Bristol-Myers Squibb , Reeds Lane, Moreton, Merseyside CH46 1QW, U.K.

出版信息

Mol Pharm. 2017 Feb 6;14(2):377-385. doi: 10.1021/acs.molpharmaceut.6b00722. Epub 2017 Jan 20.

Abstract

A generalized screening approach, applying isothermal calorimetry at 37 °C 100% RH, to formulations of spray dried dispersions (SDDs) for two active pharmaceutical ingredients (APIs) (BMS-903452 and BMS-986034) is demonstrated. APIs 452 and 034, with similar chemotypes, were synthesized and promoted during development for oral dosing. Both APIs were formulated as SDDs for animal exposure studies using the polymer hydroxypropylmethlycellulose acetyl succinate M grade (HPMCAS-M). 452 formulated at 30% (wt/wt %) was an extremely robust SDD that was able to withstand 40 °C 75% RH open storage conditions for 6 months with no physical evidence of crystallization or loss of dissolution performance. Though 034 was a chemical analogue with similar physical chemical properties to 452, a physically stable SDD of 034 could not be formulated in HPMCAS-M at any of the drug loads attempted. This study was used to develop experience with specific physical characterization laboratory techniques to evaluate the physical stability of SDDs and to characterize the propensity of SDDs to phase separate and possibly crystallize. The screening strategy adopted was to stress the formulated SDDs with a temperature humidity screen, within the calorimeter, and to apply orthogonal analytical techniques to gain a more informed understanding of why these SDDs formulated with HPMCAS-M demonstrated such different physical stability. Isothermal calorimetry (thermal activity monitor, TAM) was employed as a primary stress screen wherein the SDD formulations were monitored for 3 days at 37 °C 100% RH for signs of phase separation and possible crystallization of API. Powder X-ray diffraction (pXRD), modulated differential scanning calorimetry (mDSC), Fourier transform infrared spectroscopy (FTIR), and solid state nuclear magnetic resonance (ssNMR) were all used to examine formulated SDDs and neat amorphous drug. 452 SDDs formulated at 30% (wt/wt %) or less did not show phase separation behavior upon exposure to 37 °C 100% RH for 3 days. 034 SDD formulations from 10 through 50% (wt/wt %) all demonstrated thermal traces consistent with exothermic phase separation events over 3 days at 37 °C 100% RH in the TAM. However, only the 15, 30, and 50% containing 034 samples showed pXRD patterns consistent with crystalline material in post-TAM samples. Isothermal calorimetry is a useful screening tool to probe robust SDD physical performance and help investigate the level of drug polymer miscibility under a humid stress. Orthogonal analytical techniques such as pXRD, ssNMR, and FTIR were key in this SDD formulation screening to gain physical understanding and confirm or refute whether physical changes occur during the observed thermal events characterized by the calorimetric screening experiments.

摘要

本文展示了一种通用的筛选方法,即在37°C、100%相对湿度条件下应用等温滴定量热法,对两种活性药物成分(API)(BMS-903452和BMS-986034)的喷雾干燥分散体(SDD)制剂进行研究。化学类型相似的API 452和034在开发过程中被合成并用于口服给药的推广。两种API均被制成SDD用于动物暴露研究,使用的聚合物为羟丙基甲基纤维素乙酰琥珀酸酯M级(HPMCAS-M)。以30%(重量/重量%)配制的452是一种极其稳定的SDD,能够在40°C、75%相对湿度的开放储存条件下存放6个月,没有结晶的物理迹象或溶解性能的损失。尽管034是与452具有相似物理化学性质的化学类似物,但在尝试的任何药物负载量下,都无法在HPMCAS-M中配制出物理稳定的034 SDD。本研究旨在积累使用特定物理表征实验室技术评估SDD物理稳定性以及表征SDD相分离和可能结晶倾向的经验。所采用的筛选策略是在量热仪内通过温度湿度筛选对配制好的SDD进行强化处理,并应用正交分析技术,以便更深入地了解为什么用HPMCAS-M配制的这些SDD表现出如此不同的物理稳定性。等温滴定量热法(热活性监测仪,TAM)被用作主要的强化筛选方法,其中在37°C、100%相对湿度条件下对SDD制剂进行3天监测,以寻找API相分离和可能结晶的迹象。粉末X射线衍射(pXRD)、调制差示扫描量热法(mDSC)、傅里叶变换红外光谱(FTIR)和固态核磁共振(ssNMR)均用于检查配制好的SDD和纯无定形药物。以30%(重量/重量%)或更低比例配制的452 SDD在暴露于37°C、100%相对湿度3天后未表现出相分离行为。在TAM中,10%至50%(重量/重量%)的034 SDD制剂在37°C、100%相对湿度下放置3天均显示出与放热相分离事件一致的热曲线。然而,只有含034的15%、30%和50%样品在TAM后的样品中显示出与结晶物质一致的pXRD图谱。等温滴定量热法是一种有用的筛选工具,可用于探究稳定的SDD物理性能,并有助于研究在潮湿应力下药物与聚合物的混溶程度。诸如pXRD、ssNMR和FTIR等正交分析技术在该SDD制剂筛选中至关重要,有助于从物理角度理解并确认或反驳在量热筛选实验所表征的观察到的热事件过程中是否发生了物理变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验